Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fellows’ Forum Case Report: Progressive Weakness and Debilitation with Skin Rash

Usman T. Malik, MBBS  |  Issue: December 2017  |  December 19, 2017

The Presentation

lzf / SHUTTERSTOCK.COM

lzf / SHUTTERSTOCK.COM

A pale, quiet woman—her mother—wheeled the girl into my clinic. It was a blistering Florida day, and the girl was shivering. She glanced up at me when I said hello and asked her name.

“Hi,” she said, giving me a broad smile. Her smile was the only broad thing about her. Her elbows and knees had contractured, twisting her into a narrow curlicue of herself. “Thank you for seeing me.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“You’re very welcome. Tell me what brings you here.”

“Two years ago, I used to run 5Ks,” she said, “and now I can’t. Now,” she said, looking me in the eyes, “I’m here.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I looked back at her, tried a smile, turned to the computer screen and typed.

We’re in Gainesville at the University of Florida. It’s a nice place. I like being here. I like that, after a hiatus of six years working as a hospitalist in a relatively under-resourced location two hours away, referring complex patients to a higher level of help, now I am that higher level of help. I’m training to be a subspecialist, a rheumatologist—or so I hope.

This is where the patients I used to refer—helpless, dread-filled people, benighted by their disease—come. This young woman here is one of them, and now I am the one filled with dread.

History

Her local rheumatologist sent her to us. She is 23 years old.

We went over her disease course. Two years ago, she could run miles, and now she can’t. A mysterious weakness had raged through her, weakening her muscles, inflaming her joints, enervating her until she was bedbound. She has had multiple hospitalizations in different community hospitals, interminable wait times for test results—for an answer—biopsies of her liver, muscles, skin, and the calcium deposits that had erupted everywhere. One year ago, she had responded to plasma exchange a neurologist ordered for her when she was hospitalized. She walked for a week before her strength rapidly waned.

She used to waitress, humming songs to herself, as she paid her way through college, and now she can’t. One neurologist. Two rheumatologists. Two dermatologists. More waiting. More tests, more flares, more unknowns. Unfamiliar terms, such as autoimmune disease, ALS, seronegative lupus, chronic Lyme disease, scleroderma and overlap syndrome had been incessantly thrown at her.

Back to the Present

So now she was here in my Fellows Continuity Clinic. Debilitated, twisted and in pain, and she wanted hope or death. In her eyes I saw both. The ravages of mind and body she had undergone had marked her permanently, and I was afraid. But I thought I knew what she had.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMyositisOther Rheumatic Conditions Tagged with:amyopathyAutoimmune diseaseClinicaldermatomyositisDiagnosisfellowFellowsFellows Foruminflammatory myopathymuscle weaknessoutcomepatient carepolymyopathyRheumatic DiseaserheumatologistrheumatologysymptomTestTreatment

Related Articles
    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Tashatuvango / shutterstock.com

    Myositis-Specific Antibodies Identified

    January 16, 2020

    The idiopathic inflammatory myopathies (IIM) encompass eight categories: 1) dermatomyositis (DM) in adults, 2) juvenile dermatomyositis, 3) amyopathic DM, 4) cancer-associated DM, 5) polymyositis, 6) immune-mediated necrotizing myopathy, 7) inclusion body myositis, and 8) overlap myositis.1 These categories help classify the myopathies based on clinical and histologic features. The incidence of IIM is estimated at…

    Cancer-Associated Myositis: A Case Report & Review of the Literature

    Cancer-Associated Myositis: A Case Report & Review of the Literature

    February 17, 2019

    Since it was first reported in 1916, a correlation between inflammatory myopathies and cancer has been noted in several studies. Population studies have confirmed this relationship, and the phrase cancer-associated myopathy has entered the vernacular. Over the past decade, research efforts have shifted toward revealing associations between autoantibodies and clinical phenotypes. One subset of auto-antigens…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences